VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 377 filers reported holding VANECK VECTORS ETF TR in Q1 2017. The put-call ratio across all filers is 1.21 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $31,169 | -99.4% | 1,035,192 | +404.1% | 2.95% | +259.0% |
| Q3 2022 | $4,953,000 | -83.4% | 205,368 | -81.1% | 0.82% | -81.9% |
| Q2 2022 | $29,775,000 | +66.4% | 1,087,482 | +133.1% | 4.54% | +134.7% |
| Q1 2022 | $17,892,000 | +19.9% | 466,554 | -7.9% | 1.93% | +43.1% |
| Q3 2021 | $14,926,000 | -51.3% | 506,491 | -51.6% | 1.35% | +45.9% |
| Q4 2019 | $30,658,000 | +1.0% | 1,047,074 | -11.8% | 0.93% | -21.4% |
| Q2 2019 | $30,359,000 | +1159.2% | 1,187,759 | +998.8% | 1.18% | +2256.0% |
| Q2 2018 | $2,411,000 | -96.5% | 108,100 | -96.3% | 0.05% | -95.0% |
| Q4 2017 | $68,495,000 | +71.4% | 2,947,300 | +69.3% | 1.01% | +121.3% |
| Q3 2017 | $39,966,000 | -67.8% | 1,740,700 | -70.7% | 0.46% | -85.4% |
| Q4 2016 | $124,302,000 | +76.1% | 5,941,800 | +122.4% | 3.13% | +34.2% |
| Q3 2016 | $70,602,000 | – | 2,671,300 | – | 2.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |